Coagulation Changes during the Steady State in Homozygous Sickle‐Cell Disease in Jamaica
- 1 June 1975
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 30 (2), 159-166
- https://doi.org/10.1111/j.1365-2141.1975.tb00530.x
Abstract
Summary. Coagulation studies were carried out in 117 Jamaicans with homo‐zygous sickle‐cell disease in the steady state, and 40 local controls. The patients had significantly higher factor‐VIII levels, higher platelet counts, lower factor‐V and plasminogen levels, shorter thrombin times and higher serum fibrinogen degradation products (FDP) than the control group. The low factor‐V and plasminogen levels, and high FDP levels, might be explained by activation of the coagulation system and continuous clot lysis even in the absence of painful crisis. The high factor‐VIII levels and short thrombin times found in these patients could not be explained.Keywords
This publication has 19 references indexed in Scilit:
- SPECIFIC AND SENSITIVE DETERMINATION OF FIBRINOGEN-DEGRADATION PRODUCTS BY RADIOIMMUNOASSAYThe Lancet, 1973
- Fibrinogen-Fibrin Degradation Product Levels in Different Types of Intravascular HaemolysisBMJ, 1973
- Microangiopathic Haemolytic Anaemia (MHA)British Journal of Haematology, 1972
- Activated Coagulation Factors: In-Vivo and in-Vitro StudiesBritish Journal of Haematology, 1969
- Fibrinolytic activity and sickle-cell crises.BMJ, 1969
- Fibrinolytic activity in the clinical crisis of sickle-cell anaemia.BMJ, 1967
- Partial thromboplastin time test with kaolin: diagnosis of haemophilia and Christmas disease without natural reference plasmasJournal of Clinical Pathology, 1967
- Factor-VIII (Antihaemophilic Factor) Activity in Sickle-Cell AnaemiaBritish Journal of Haematology, 1967
- Blood Coagulation and Intravascular HemolysisScandinavian Journal of Clinical and Laboratory Investigation, 1962
- SOME SYSTEMATIC EXPERIMENTAL DESIGNSBiometrika, 1951